Gritstone Bio Inc (GRTS)
0.7798
-0.03
(-4.07%)
USD |
NASDAQ |
Apr 25, 12:45
Gritstone Bio Debt to Equity Ratio: 0.7742 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7742 |
| September 30, 2023 | 0.4037 |
| June 30, 2023 | 0.2713 |
| March 31, 2023 | 0.2099 |
| December 31, 2022 | 0.1133 |
| September 30, 2022 | 0.1409 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.7742
Maximum
Dec 2023
0.1007
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Precision BioSciences Inc | 1.188 |
| Humacyte Inc | -- |
| Verastem Inc | -- |
| BioVie Inc | -- |
| Syros Pharmaceuticals Inc | 2.474 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 177.77M |
| Total Liabilities (Quarterly) | 125.92M |
| Shareholders Equity (Quarterly) | 51.85M |
| Current Ratio | 3.198 |
| Net Debt Paydown Yield | -2.10% |